Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1954 May;33(5):753–758. doi: 10.1172/JCI102944

STUDIES OF MICROBIAL POPULATIONS ARTIFICIALLY LOCALIZED IN VIVO. II. DIFFERENCE IN ANTITYPHOIDAL ACTIVITIES OF CHLORAMPHENICOL AND CHLORTETRACYCLINE 1

Charles A Werner 1,2, Walsh McDermott 1, Carol Adams 1, Rebeckah DuBois 1
PMCID: PMC438506  PMID: 13163164

Full text

PDF
753

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Broschard R. W., Dornbush A. C., Gordon S., Hutchings B. L., Kohler A. R., Krupka G., Kushner S., Lefemine D. V., Pidacks C. Aureomycin, a New Antibiotic. Science. 1949 Feb 25;109(2826):199–200. doi: 10.1126/science.109.2826.199-a. [DOI] [PubMed] [Google Scholar]
  2. EAGLE H. Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice. Am J Med. 1952 Oct;13(4):389–399. doi: 10.1016/0002-9343(52)90293-3. [DOI] [PubMed] [Google Scholar]
  3. Goodpasture E. W. Concerning the Pathogenesis of Typhoid Fever. Am J Pathol. 1937 Mar;13(2):175–186.5. [PMC free article] [PubMed] [Google Scholar]
  4. KNIGHT V., RUIZ SANCHEZ F. Antimicrobial therapy in typhoid. Arch Intern Med (Chic) 1950 Jan;85(1):44–82. doi: 10.1001/archinte.1950.00230070066004. [DOI] [PubMed] [Google Scholar]
  5. KNIGHT V., RUIZ-SANCHEZ F., McDERMOTT W. Chloramphenicol in the treatment of the acute manifestations of brucellosis. Am J Med Sci. 1950 Jun;219(6):627–638. doi: 10.1097/00000441-195006000-00005. [DOI] [PubMed] [Google Scholar]
  6. MACKANESS G. B., SMITH N. The bactericidal action of isoniazid, streptomycin and terramycin on extracellular and intracellular tubercle bacilli. Am Rev Tuberc. 1953 Mar;67(3):322–340. doi: 10.1164/art.1953.67.3.322. [DOI] [PubMed] [Google Scholar]
  7. McLean I. W., Schwab J. L., Hillegas A. B., Schlingman A. S. SUSCEPTIBILITY OF MICRO-ORGANISMS TO CHLORAMPHENICOL (CHLOROMYCETIN). J Clin Invest. 1949 Sep;28(5 Pt 1):953–963. doi: 10.1172/JCI102185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Paine T. F., Jr, Collins H. S., Finland M. Bacteriologic Studies on Aureomycin. J Bacteriol. 1948 Oct;56(4):489–497. doi: 10.1128/jb.56.4.489-497.1948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. SHAFFER J. M., KUCERA C. J., SPINK W. W. The protection of intracellular brucella against therapeutic agents and the bactericidal action of serum. J Exp Med. 1953 Jan;97(1):77–90. doi: 10.1084/jem.97.1.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. WERNER C. A., KNIGHT V., McDERMOTT W. Absorption and excretion of terramycin in humans: comparison with aureomycin and chloramphenicol. Proc Soc Exp Biol Med. 1950 Jun;74(2):261–267. doi: 10.3181/00379727-74-17872. [DOI] [PubMed] [Google Scholar]
  11. WERNER C. A., KNIGHT V., McDERMOTT W. Studies of microbial populations artificially localized in vivo. I. Multiplication of bacteria and distribution of drugs in agar loci. J Clin Invest. 1954 May;33(5):742–752. doi: 10.1172/JCI102943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. WOODWARD T. E., SMADEL J. E., PARKER R. T., WISSEMAN C. L., Jr Treatment of typhoid fever with antibiotics. Ann N Y Acad Sci. 1952 Dec 30;55(6):1043–1055. doi: 10.1111/j.1749-6632.1952.tb22663.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES